{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05065372",
            "orgStudyIdInfo": {
                "id": "21-3483"
            },
            "secondaryIdInfos": [
                {
                    "id": "K23HL159292",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/K23HL159292"
                }
            ],
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes",
            "officialTitle": "MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes",
            "acronym": "MANATEE-T1D",
            "therapeuticArea": [
                "Endocrinology",
                "Nephrology and Renal Diseases",
                "Other"
            ],
            "study": "manatee-metformin-and-automated-insulin-delivery-system-effects-on-renal-vascular-resistance-insulin-sensitivity-and-cardiometabolic-function-in-youth-with-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-07-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-13",
            "studyFirstSubmitQcDate": "2021-09-22",
            "studyFirstPostDateStruct": {
                "date": "2021-10-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Diabetic kidney disease and cardiovascular disease remain the leading causes of morbidity and mortality in people with type 1 diabetes and are exacerbated with longer duration of diabetes and time outside goal glycemic range. Yet, type 1 diabetes is a complex disease with pathophysiology that extends beyond beta-cell injury and insulin deficiency to include insulin resistance and renal vascular resistance, factors that accelerate cardiovascular disease risk. We have shown that metformin improved peripheral insulin sensitivity and vascular stiffness in youth with type 1 diabetes on multiple daily insulin injections or standard insulin pumps. However, metformin's effect on kidney and endothelial outcomes, and the effects of type 1 diabetes technologies, with or without metformin, on any cardiovascular or kidney outcome, remains unknown. Automated insulin delivery systems combine an insulin pump, continuous glucose monitor, and control algorithm to modulate background insulin delivery and decrease peripheral insulin exposure while improving time in target range and reducing hypoglycemia. We hypothesize that automated insulin delivery systems, particularly when combined with metformin, may modulate renal vascular resistance and insulin sensitivity, thereby impacting cardiometabolic function. MANATEE-T1D is a randomized, double-blind, placebo-controlled trial of 4 months of metformin 2,000 mg daily in 40 youth aged 12-21 years with type 1 diabetes on automated insulin delivery systems vs. 20 control youth with type 1 diabetes on multiple daily injections plus a continuous glucose monitor or an insulin pump in manual mode plus a continuous glucose monitor which will assess for changes in calculated renal vascular resistance and gold standard measures of whole-body and adipose insulin sensitivity, arterial stiffness, and endothelial function."
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes",
                "Diabetic Kidney Disease",
                "Cardiovascular Diseases",
                "Endothelial Dysfunction",
                "Insulin Sensitivity"
            ],
            "keywords": [
                "Type 1 diabetes",
                "Youth",
                "Insulin sensitivity",
                "Cardiovascular function",
                "Diabetic kidney disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Metformin plus automated insulin delivery system",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Some participants with type 1 diabetes using an automated insulin delivery system will be randomized to receive treatment with metformin and will undergo RPF (Aminohippurate Sodium Injections 20%), GFR (Iohexol Inj 300 MG/ML), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) assessments, in additional to assessments of cardiovascular and endothelial function.",
                    "interventionNames": [
                        "Drug: Metformin Hcl 1000Mg Tab",
                        "Drug: Aminohippurate Sodium 20 % Injection",
                        "Drug: Iohexol 300 Mg/mL Injectable Solution"
                    ]
                },
                {
                    "label": "Placebo plus automated insulin delivery system",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Some participants with type 1 diabetes using an automated insulin delivery system will be randomized to receive treatment with a placebo pill which is identical in appearance to the metformin pill and will undergo RPF (Aminohippurate Sodium Injections 20%), GFR (Iohexol Inj 300 MG/ML), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) assessments, in additional to assessments of cardiovascular and endothelial function.",
                    "interventionNames": [
                        "Drug: Aminohippurate Sodium 20 % Injection",
                        "Drug: Iohexol 300 Mg/mL Injectable Solution",
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Multiple daily insulin injections plus continuous glucose monitor",
                    "type": "OTHER",
                    "description": "Participants with type 1 diabetes using multiple daily injections plus a continuous glucose monitor will not be randomized to receive medication treatment but will undergo RPF (Aminohippurate Sodium Injections 20%), GFR (Iohexol Inj 300 MG/ML), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) assessments, in additional to assessments of cardiovascular and endothelial function.",
                    "interventionNames": [
                        "Drug: Aminohippurate Sodium 20 % Injection",
                        "Drug: Iohexol 300 Mg/mL Injectable Solution"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Metformin Hcl 1000Mg Tab",
                    "description": "Agent used to modify insulin sensitivity",
                    "armGroupLabels": [
                        "Metformin plus automated insulin delivery system"
                    ],
                    "otherNames": [
                        "Fortamet",
                        "Glucophage",
                        "Glumetza",
                        "Riomet"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Aminohippurate Sodium 20 % Injection",
                    "description": "Diagnostic aid/agent used to measure renal plasma flow and calculate renal vascular resistance",
                    "armGroupLabels": [
                        "Metformin plus automated insulin delivery system",
                        "Multiple daily insulin injections plus continuous glucose monitor",
                        "Placebo plus automated insulin delivery system"
                    ],
                    "otherNames": [
                        "Sodium 4-amino hippurate (PAH) injection 20% (2g/10 mL)",
                        "Para-aminohippurate",
                        "Aminohippuric acid"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Iohexol 300 Mg/mL Injectable Solution",
                    "description": "Diagnostic aid/agent used to measure glomerular filtration rate",
                    "armGroupLabels": [
                        "Metformin plus automated insulin delivery system",
                        "Multiple daily insulin injections plus continuous glucose monitor",
                        "Placebo plus automated insulin delivery system"
                    ],
                    "otherNames": [
                        "Omnipaque 300"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Identical to Metformin Hcl 1000Mg Tab but without metabolic effects",
                    "armGroupLabels": [
                        "Placebo plus automated insulin delivery system"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Renal vascular resistance",
                    "description": "Renal plasma flow will be measured by para-aminohippurate clearance and used to calculate renal vascular resistance",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Glomerular filtration rate",
                    "description": "Measured by iohexol clearance",
                    "timeFrame": "4 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Arterial stiffness",
                    "description": "Measured by SphygmoCor",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Endothelial function",
                    "description": "Measured by EndoPAT",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Insulin sensitivity",
                    "description": "Measured by hyperinsulinemic-euglycemic clamp",
                    "timeFrame": "4 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Youth with pancreatic antibody positive type 1 diabetes\n* Age 12-25 years\n* Use of an automated insulin delivery system or multiple daily insulin injections plus a continuous glucose monitor or an insulin pump in manual mode plus a continuous glucose monitor for \\> 6 months\n* Pubertal\n* Weight \\> 54 kg and BMI \\> 5th percentile for age and sex\n* Hemoglobin A1c \\< 11%\n* No recent episodes of diabetic ketoacidosis (DKA) or hyperglycemic hyperosmolar syndrome (HHS)\n\nExclusion Criteria:\n\n* Blood pressure \\> 140/90 mm Hg\n* Anemia\n* Estimated glomerular filtration rate \\< 60 mL/min/1.73 m2 or serum creatinine \\> 1.2 mg/dL or history of urinary albumin to creatinine ratio \u2265 300mg/g or history of acute kidney injury\n* Use of anti-diabetic agents except insulin, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB's), diuretics, daily non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin, sulfonamides, procaine, thiazosulfone or probenecid\n* Seafood or iodine allergy\n* Pregnancy or breast feeding for females",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "25 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kalie Tommerdahl, MD",
                    "role": "CONTACT",
                    "phone": "720-777-6128",
                    "email": "Kalie.Tommerdahl@childrenscolorado.org"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz Medical Campus",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kalie Tommerdahl, MD",
                            "role": "CONTACT",
                            "phone": "720-777-6128",
                            "email": "Kalie.Tommerdahl@childrenscolorado.org"
                        },
                        {
                            "name": "Kalie Tommerdahl, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000003928",
                    "term": "Diabetic Nephropathies"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                },
                {
                    "id": "D000007333",
                    "term": "Insulin Resistance"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "asFound": "Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7123",
                    "name": "Diabetic Nephropathies",
                    "asFound": "Diabetic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "asFound": "Insulin Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008687",
                    "term": "Metformin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11667",
                    "name": "Metformin",
                    "asFound": "Gallbladder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}